Aerie Pharmaceuticals
Utility Patents

Last updated:

List of all Aerie Pharmaceuticals patents 22 in total

Status Patent
Grant
Utility: Ophthalmic compositions External link
Filling date: 8 Sep 2025 Issue date: 19 Jul 2022
Grant
Utility: Aryl cyclopropyl-amino-isoquinolinyl amide compounds External link
Filling date: 8 Sep 2025 Issue date: 26 Apr 2022
Grant
Utility: Combination therapy External link
Filling date: 8 Sep 2025 Issue date: 14 Dec 2021
Grant
Utility: Compositions for treating glaucoma or reducing intraocular pressure External link
Filling date: 8 Sep 2025 Issue date: 30 Nov 2021
Grant
Utility: Compounds, compositions and methods for treatment of myopia External link
Filling date: 8 Sep 2025 Issue date: 14 Sep 2021
Grant
Utility: Intravitreal drug delivery systems for the treatment of ocular conditions External link
Filling date: 8 Sep 2025 Issue date: 14 Sep 2021
Grant
Utility: Isoquinoline-steroid conjugates and uses thereof External link
Filling date: 8 Sep 2025 Issue date: 13 Jul 2021
Grant
Utility: Dual mechanism inhibitors for the treatment of disease External link
Filling date: 8 Sep 2025 Issue date: 8 Jun 2021
Grant
Utility: Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds External link
Filling date: 8 Sep 2025 Issue date: 1 Jun 2021
Grant
Utility: Combination therapy External link
Filling date: 8 Sep 2025 Issue date: 1 Jun 2021
Grant
Utility: 6-aminoisoquinoline compounds External link
Filling date: 8 Sep 2025 Issue date: 26 Jan 2021
Grant
Utility: Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds External link
Filling date: 8 Sep 2025 Issue date: 5 Jan 2021
Grant
Utility: Aryl cyclopropyl-amino-isoquinolinyl amide compounds External link
Filling date: 8 Sep 2025 Issue date: 8 Dec 2020
Grant
Utility: Implant applicators and methods of administering implants External link
Filling date: 8 Sep 2025 Issue date: 1 Dec 2020
Grant
Utility: Dual mechanism inhibitors for the treatment of disease External link
Filling date: 8 Sep 2025 Issue date: 19 May 2020
Grant
Utility: Rho kinase inhibitors External link
Filling date: 8 Sep 2025 Issue date: 21 Apr 2020
Grant
Utility: Intravitreal drug delivery systems for the treatment of ocular conditions External link
Filling date: 8 Sep 2025 Issue date: 21 Apr 2020
Grant
Utility: Combination therapy External link
Filling date: 8 Sep 2025 Issue date: 17 Mar 2020
Grant
Utility: Combination therapy External link
Filling date: 8 Sep 2025 Issue date: 25 Feb 2020
Grant
Utility: Process for the preparation of kinase inhibitors and intermediates thereof External link
Filling date: 8 Sep 2025 Issue date: 4 Feb 2020
Grant
Utility: Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds External link
Filling date: 8 Sep 2025 Issue date: 14 Jan 2020
Grant
Utility: 6-aminoisoquinoline compounds External link
Filling date: 8 Sep 2025 Issue date: 12 Nov 2019

Showing 1 to 22 of 22 patents.